PapersFlow Research Brief
Nail Diseases and Treatments
Research Guide
What is Nail Diseases and Treatments?
Nail diseases and treatments encompass the epidemiological trends, diagnosis, and management of fungal nail infections such as onychomycosis caused by dermatophytes, along with associated conditions like seborrheic dermatitis and tinea capitis, including antifungal therapies and pathogen virulence traits.
This field covers 89,975 papers on fungal skin and nail infections, focusing on onychomycosis, dermatophytes, Malassezia, and related conditions. "Epidemiological trends in skin mycoses worldwide" by Havlíčková et al. (2008) states that 20–25% of the world’s population has skin mycoses, one of the most frequent infection types. Growth rate over the past 5 years is not available.
Topic Hierarchy
Research Sub-Topics
Onychomycosis Epidemiology
This sub-topic examines the prevalence, incidence, risk factors, and global distribution of onychomycosis, the most common nail fungal infection. Researchers analyze demographic trends, comorbidities like diabetes, and regional variations in disease burden.
Dermatophyte Antifungal Susceptibility
This sub-topic investigates in vitro and in vivo antifungal resistance patterns among dermatophytes causing nail infections. Researchers study mechanisms of resistance to terbinafine, azoles, and emerging therapies.
Onychomycosis Diagnostic Techniques
This sub-topic covers advancements in microscopy, PCR, culture, and dermoscopy for accurate diagnosis of nail fungal infections. Researchers evaluate sensitivity, specificity, and clinical utility of these methods.
Oral Antifungal Therapy for Onychomycosis
This sub-topic explores pharmacokinetics, efficacy, and safety of oral agents like terbinafine and itraconazole for treating onychomycosis. Researchers conduct comparative trials and long-term follow-up studies.
Dermatophyte Virulence Factors
This sub-topic delves into molecular mechanisms like keratinases, adhesins, and biofilm formation enabling dermatophytes to infect nails. Researchers use genomics and animal models to identify key virulence traits.
Why It Matters
Nail diseases like onychomycosis impose a substantial global burden due to their high prevalence and impact on quality of life. Havlíčková et al. (2008) report that fungal infections of the skin and nails affect 20–25% of the world’s population, with pathogens primarily dermatophytes responsible for conditions such as tinea capitis and onychomycosis. Effective management relies on antifungal susceptibility patterns and therapies, as seen in guidelines for related mycoses like cryptococcosis (Perfect et al., 2010) and histoplasmosis (Wheat et al., 2007), which inform treatment strategies for nail infections. The skin microbiome, detailed by Grice and Segre (2011) and Byrd et al. (2018), influences infection susceptibility, aiding targeted diagnostics and interventions in dermatology.
Reading Guide
Where to Start
"Epidemiological trends in skin mycoses worldwide" by Havlíčková et al. (2008), as it provides foundational prevalence data (20–25% global rate) and pathogen overview essential for understanding nail diseases like onychomycosis.
Key Papers Explained
"Epidemiological trends in skin mycoses worldwide" by Havlíčková et al. (2008) establishes global prevalence, which Grice and Segre (2011) in "The skin microbiome" contextualizes via microbial ecology influencing dermatophyte infections; Byrd et al. (2018) in "The human skin microbiome" builds on this by detailing host-pathogen interactions relevant to nail mycoses. "Textbook of dermatology" by Rook et al. (1968) offers comprehensive disease descriptions that connect to these trends.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Focus on antifungal therapies and virulence, drawing from Perfect et al. (2010) and Wheat et al. (2007) guidelines for analogous mycoses; no recent preprints available.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | The skin microbiome | 2011 | Nature Reviews Microbi... | 3.0K | ✓ |
| 2 | Clinical Practice Guidelines for the Management of Cryptococca... | 2010 | Clinical Infectious Di... | 2.6K | ✓ |
| 3 | The human skin microbiome | 2018 | Nature Reviews Microbi... | 2.5K | ✓ |
| 4 | Textbook of dermatology | 1968 | Medical Entomology and... | 1.6K | ✕ |
| 5 | Histopathological changes preceding spontaneous rupture of a t... | 1991 | Journal of Bone and Jo... | 1.5K | ✕ |
| 6 | Aspergillosis Case-Fatality Rate: Systematic Review of the Lit... | 2001 | Clinical Infectious Di... | 1.4K | ✕ |
| 7 | Clinical Practice Guidelines for the Management of Patients wi... | 2007 | Clinical Infectious Di... | 1.3K | ✕ |
| 8 | Epidemiological trends in skin mycoses worldwide | 2008 | Mycoses | 1.3K | ✕ |
| 9 | Posaconazole or Fluconazole for Prophylaxis in Severe Graft-ve... | 2007 | New England Journal of... | 1.3K | ✓ |
| 10 | Virulence factors of Candida albicans | 2001 | Trends in Microbiology | 1.3K | ✕ |
Frequently Asked Questions
What is the global prevalence of skin and nail mycoses?
Fungal infections of the skin and nails affect 20–25% of the world’s population. "Epidemiological trends in skin mycoses worldwide" by Havlíčková et al. (2008) identifies these as one of the most frequent infection types globally. Dermatophytes are the primary pathogens responsible.
How does the skin microbiome relate to nail diseases?
"The skin microbiome" by Grice and Segre (2011) examines microbial communities on human skin that influence fungal infection susceptibility, including onychomycosis. "The human skin microbiome" by Byrd et al. (2018) expands on these dynamics in disease contexts. These factors aid in understanding nail infection pathogenesis.
What pathogens cause nail infections like onychomycosis?
Dermatophytes are the primary pathogens for skin and nail mycoses, including onychomycosis, as noted in the field description and Havlíčková et al. (2008). Malassezia contributes to associated conditions like seborrheic dermatitis. Virulence traits of related fungi are discussed in Calderone and Fonzi (2001).
What treatments are used for fungal nail diseases?
Antifungal therapies target dermatophytes and other pathogens in onychomycosis management. Guidelines like Perfect et al. (2010) for cryptococcosis and Wheat et al. (2007) for histoplasmosis provide models for antifungal use. Susceptibility patterns guide therapy selection.
What is the current state of nail disease epidemiology?
The field includes 89,975 papers on epidemiology, diagnosis, and management of nail infections. Havlíčková et al. (2008) document worldwide trends showing high prevalence. No recent preprints or news updates are available.
Open Research Questions
- ? How do virulence traits of dermatophytes specifically contribute to onychomycosis persistence in nails?
- ? What are the antifungal susceptibility patterns of Malassezia in seborrheic dermatitis associated with nail infections?
- ? How does the skin microbiome modulate the global burden of tinea capitis and onychomycosis?
- ? What histopathological changes precede chronic nail fungal infections analogous to tendon ruptures?
Recent Trends
The field maintains 89,975 papers with no specified 5-year growth rate; Havlíčková et al. remains a key reference for 20–25% global prevalence of skin mycoses, including nail infections.
2008No recent preprints or news coverage in the last 12 months reported.
Research Nail Diseases and Treatments with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Nail Diseases and Treatments with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers